These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18224429)

  • 1. Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation.
    Alexandraki KI; Piperi C; Ziakas PD; Apostolopoulos NV; Makrilakis K; Syriou V; Diamanti-Kandarakis E; Kaltsas G; Kalofoutis A
    J Clin Immunol; 2008 Jul; 28(4):314-21. PubMed ID: 18224429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus.
    Bozluolcay M; Andican G; Fırtına S; Erkol G; Konukoglu D
    Geriatr Gerontol Int; 2016 Oct; 16(10):1161-1166. PubMed ID: 26337250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Resolution of Diabetes: C-C Chemokine Motif Ligand 4 Is a Common Target in Different Types of Diabetes by Protecting Pancreatic Islet Cell and Modulating Inflammation.
    Chang TT; Lin LY; Chen JW
    Front Immunol; 2021; 12():650626. PubMed ID: 33968046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children.
    Erbağci AB; Tarakçioğlu M; Coşkun Y; Sivasli E; Sibel Namiduru E
    Clin Biochem; 2001 Nov; 34(8):645-50. PubMed ID: 11849625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Expression of Apoptotic and Low-Grade Inflammatory Markers in Alzheimer Disease Compared to Diabetes Mellitus Type 1 and 2.
    Alexandraki KI; Apostolopoulos NV; Adamopoulos C; Stamouli E; Dalagiorgou G; Papaioannou TG; Analitis A; Karamanou M; Makrilakis K; Politis A; Piperi C
    J Appl Lab Med; 2019 May; 3(6):1003-1013. PubMed ID: 31639691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocytic expression behavior of cytokines in diabetic patients upon inflammatory stimulation.
    Giulietti A; Stoffels K; Decallonne B; Overbergh L; Mathieu C
    Ann N Y Acad Sci; 2004 Dec; 1037():74-8. PubMed ID: 15699496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ro52/TRIM21-deficient expression and function in different subsets of peripheral blood mononuclear cells is associated with a proinflammatory cytokine response in patients with idiopathic inflammatory myopathies.
    Gómez-Martín D; Galindo-Feria AS; Barrera-Vargas A; Merayo-Chalico J; Juárez-Vega G; Torres-Ruiz J; Alcocer-Varela J
    Clin Exp Immunol; 2017 Apr; 188(1):154-162. PubMed ID: 27936488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood mononuclear cells of patients with latent autoimmune diabetes secrete higher levels of pro- & anti-inflammatory cytokines compared to those with type-1 diabetes mellitus following
    Badal D; Kumar R; Paul M; Dayal D; Bhansali A; Bhadada SK; Kumar R; Sachdeva N
    Indian J Med Res; 2017 Jun; 145(6):767-776. PubMed ID: 29067979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a More Disrupted Immune-Endocrine Relation and Cortisol Immunologic Influences in the Context of Tuberculosis and Type 2 Diabetes Comorbidity.
    Fernández RDV; Díaz A; Bongiovanni B; Gallucci G; Bértola D; Gardeñez W; Lioi S; Bertolin Y; Galliano R; Bay ML; Bottasso O; D'Attilio L
    Front Endocrinol (Lausanne); 2020; 11():126. PubMed ID: 32265833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 expression and its association with low-grade inflammation in a Greek population of type 1 diabetic juveniles: evidence for differences in CD40 mRNA isoforms expressed by peripheral blood mononuclear cells.
    Chatzigeorgiou AE; Lembessis PE; Mylona-Karagianni CF; Tsouvalas EA; Diamanti-Kandarakis E; Kamper EF
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):38-46. PubMed ID: 19834879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM.
    Hussain MJ; Peakman M; Gallati H; Lo SS; Hawa M; Viberti GC; Watkins PJ; Leslie RD; Vergani D
    Diabetologia; 1996 Jan; 39(1):60-9. PubMed ID: 8720604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol supplementation decreases blood glucose without changing the circulating CD14
    Khodabandehloo H; Seyyedebrahimi S; Esfahani EN; Razi F; Meshkani R
    Nutr Res; 2018 Jun; 54():40-51. PubMed ID: 29914666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinone.
    El-Mahmoudy A; Shimizu Y; Shiina T; Matsuyama H; Nikami H; Takewaki T
    Acta Diabetol; 2005 Mar; 42(1):23-30. PubMed ID: 15868110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterial Hsp65 potentially cross-reacts with autoantibodies of diabetes sera and also induces (in vitro) cytokine responses relevant to diabetes mellitus.
    Rani PS; Babajan B; Tulsian NK; Begum M; Kumar A; Ahmed N
    Mol Biosyst; 2013 Nov; 9(11):2932-41. PubMed ID: 24056978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Markers of immune inflammation in patients with type 2 diabetes and obesity].
    Semenchenko IIu; Sharafetdinov KhKh; Plotnikova OA; Alekseeva RI; Sentsova TB; Vorozhko IV
    Vopr Pitan; 2013; 82(5):46-50. PubMed ID: 24640159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclear cells in patients with rheumatoid arthritis.
    Schotte H; Schlüter B; Willeke P; Mickholz E; Schorat MA; Domschke W; Gaubitz M
    Rheumatology (Oxford); 2004 Aug; 43(8):960-4. PubMed ID: 15026584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA Regulates Release of Inflammatory Cytokines From Peripheral Blood Mononuclear Cells and CD4
    Bhandage AK; Jin Z; Korol SV; Shen Q; Pei Y; Deng Q; Espes D; Carlsson PO; Kamali-Moghaddam M; Birnir B
    EBioMedicine; 2018 Apr; 30():283-294. PubMed ID: 29627388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of cytokines and GADA in type I and II diabetic patients.
    Amin K; Qadr SH; Hassan Hussein R; Ali KM; Rahman HS
    Prim Care Diabetes; 2020 Feb; 14(1):61-67. PubMed ID: 31014937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of humoral anti-endotoxin immunity and low-intensity inflammation in diabetes mellitus type 1 and 2.
    Gordienko AI; Beloglazov VA; Kubyshkin AV
    Patol Fiziol Eksp Ter; 2016; 60(3):61-7. PubMed ID: 29244909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes.
    Szpigel A; Hainault I; Carlier A; Venteclef N; Batto AF; Hajduch E; Bernard C; Ktorza A; Gautier JF; Ferré P; Bourron O; Foufelle F
    Diabetologia; 2018 Feb; 61(2):399-412. PubMed ID: 28988346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.